Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next three days.
In the meantime, you can enjoy access to all the latest news, events and resources for different therapy areas on our website.Prostatic inflammation in REDUCE study participants
20.01.2017
A recent analysis has investigated the effect of baseline inflammation on BPH-related parameters in placebo-treated participants of the 4-year REDUCE study
Risk of major cardiac adverse events in males with LUTS
20.01.2017
A systematic literature search and meta-analysis has found the risk of major cardiac adverse events is increased in males with LUTS
Sleep quality in people with LUTS and nocturia
20.01.2017
A cross-sectional study in China has investigated the effect of nocturia on sleep quality and daytime functioning, specifically in people with LUTS
Prostate size as predictor of lower urinary tract symptoms
20.01.2017
A post-hoc analysis of the REDUCE trial found that men with increased prostate size are at higher risk of incident lower urinary tract symptoms
Translational links in MetS, inflammation and LUTS
20.01.2017
A systematic review concluded that metabolic syndrome and inflammation could be important contributors to LUTS in men
Impact of storage and voiding LUTS on quality of life
20.01.2017
Structural equation modelling showed that in BPH therapy, improvements in QoL were mainly due to improvement of storage lower urinary tract symptoms
Prostatic arterial embolization for BPH
20.01.2017
A systematic review of clinical studies evaluates evidence for the use of prostatic arterial embolization in BPH with a discussion of outcomes and complications
Monotherapies for BPH remain prevalent
20.01.2017
Benign prostatic hyperplasia is commonly treated by monotherapy despite evidence from clinical trials indicating that combination therapy is more effective.
LUTS link to metabolic disorders
20.01.2017
Summary of proceedings from ICI-RS 2014 highlighting potential links between lower urinary tract symptoms and metabolic disorders.
Innovations in BPH management
20.01.2017
A review of recent technological innovations with potential clinical impact on the treatment of benign prostatic hyperplasia.
Metabolic syndrome associated with BPH in UK study
20.01.2017
A cross-sectional UK epidemiological study has shown a significant association between benign prostatic hyperplasia and metabolic syndrome.
